Marek Łoś

22.3k total citations · 6 hit papers
167 papers, 13.1k citations indexed

About

Marek Łoś is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Marek Łoś has authored 167 papers receiving a total of 13.1k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Molecular Biology, 31 papers in Epidemiology and 29 papers in Oncology. Recurrent topics in Marek Łoś's work include Cell death mechanisms and regulation (39 papers), Autophagy in Disease and Therapy (25 papers) and RNA Interference and Gene Delivery (13 papers). Marek Łoś is often cited by papers focused on Cell death mechanisms and regulation (39 papers), Autophagy in Disease and Therapy (25 papers) and RNA Interference and Gene Delivery (13 papers). Marek Łoś collaborates with scholars based in Canada, Poland and Iran. Marek Łoś's co-authors include Klaus Schulze‐Osthoff, Sebastian Wesselborg, Saeid Ghavami, Davide Ferrari, Mohammad Hashemi, Thomas Klonisch, Patrick A. Baeuerle, Marcus E. Peter, Sudharsana Rao Ande and Subbareddy Maddika and has published in prestigious journals such as Nature, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Marek Łoś

166 papers receiving 12.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Autophagy and apoptosis dysfunction in neurodegenerative disorders

2013 831 citations Saeid Ghavami, Sudharsana Rao Ande et al. profile →
Apoptosis signaling by death receptors

1998 815 citations Klaus Schulze‐Osthoff, Marek Łoś et al. profile →
Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis

1995 567 citations Marek Łoś, Patrick A. Baeuerle et al. profile →
An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment

2021 180 citations Jakub Rosik, Filip Machaj et al. Drug Resistance Updates profile →
Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma

2022 159 citations Amir Barzegar Behrooz, Marek Łoś et al. International Journal of Molecular Sciences profile →
Targeting autophagy, oxidative stress, and ER stress for neurodegenerative disease treatment

2022 130 citations Marek Łoś, Daniel J. Klionsky et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marek Łoś Canada	61	7.7k	2.4k	2.1k	2.1k	1.7k	167	13.1k
Philippe Marchetti France	62	9.9k 1.3×	2.4k 1.0×	1.4k 0.7×	2.3k 1.1×	1.6k 1.0×	177	16.1k
Catherine Brenner France	57	10.9k 1.4×	1.7k 0.7×	2.6k 1.3×	1.8k 0.9×	1.6k 0.9×	139	16.4k
Canhua Huang China	66	7.3k 1.0×	2.2k 0.9×	1.8k 0.9×	2.2k 1.1×	2.8k 1.7×	225	13.7k
Nathanaël Larochette France	36	8.7k 1.1×	2.3k 1.0×	2.8k 1.3×	3.0k 1.5×	1.1k 0.7×	48	13.9k
Stephen W. G. Tait United Kingdom	49	10.0k 1.3×	1.9k 0.8×	3.4k 1.6×	3.5k 1.7×	1.8k 1.1×	87	15.5k
Hui Wang China	62	6.7k 0.9×	2.7k 1.1×	2.1k 1.0×	3.7k 1.8×	2.0k 1.2×	708	16.0k
Hua Zhu United States	55	6.5k 0.9×	1.8k 0.8×	4.7k 2.3×	1.8k 0.9×	2.0k 1.2×	298	13.1k
Saeid Ghavami Canada	59	6.2k 0.8×	1.4k 0.6×	3.2k 1.6×	1.4k 0.7×	2.3k 1.4×	305	12.3k
Jing Liu China	59	8.9k 1.2×	1.8k 0.8×	1.3k 0.6×	1.3k 0.6×	2.3k 1.4×	564	15.4k
Wei Wei China	57	6.8k 0.9×	2.0k 0.8×	1.2k 0.6×	2.9k 1.4×	2.3k 1.4×	474	13.7k

Countries citing papers authored by Marek Łoś

Since Specialization

Citations

This map shows the geographic impact of Marek Łoś's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Łoś with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Łoś more than expected).

Fields of papers citing papers by Marek Łoś

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marek Łoś. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Łoś. The network helps show where Marek Łoś may publish in the future.

Co-authorship network of co-authors of Marek Łoś

This figure shows the co-authorship network connecting the top 25 collaborators of Marek Łoś. A scholar is included among the top collaborators of Marek Łoś based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marek Łoś. Marek Łoś is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Behrooz, Amir Barzegar, Alexandra R. Fernandes, Abdul‐Hamid Emwas, et al.. (2024). Progress in Precision Medicine for Head and Neck Cancer. Cancers. 16(21). 3716–3716.

Dehesh, Tania, Nima Taefehshokr, Katarzyna Kotfis, et al.. (2023). The Effects of Statins on Respiratory Symptoms and Pulmonary Fibrosis in COVID-19 Patients with Diabetes Mellitus: A Longitudinal Multicenter Study. Archivum Immunologiae et Therapiae Experimentalis. 71(1). 8–8. 5 indexed citations

Behrooz, Amir Barzegar, et al.. (2023). Molecular mechanisms of microRNAs in glioblastoma pathogenesis. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1870(6). 119482–119482. 11 indexed citations

Soleimanjahi, Hoorieh, et al.. (2023). A promising future in cancer immunotherapy: Oncolytic viruses. European Journal of Pharmacology. 960. 176063–176063. 7 indexed citations

Martelli, Alma, Maryam Zarghooni, Simone Brogi, et al.. (2022). New Visions on Natural Products and Cancer Therapy: Autophagy and Related Regulatory Pathways. Cancers. 14(23). 5839–5839. 24 indexed citations

Hudecki, Andrzej, Anna Kasprzycka, Alicja Kazek‐Kęsik, et al.. (2022). Comparison of Physicochemical, Mechanical, and (Micro-)Biological Properties of Sintered Scaffolds Based on Natural- and Synthetic Hydroxyapatite Supplemented with Selected Dopants. International Journal of Molecular Sciences. 23(9). 4692–4692. 8 indexed citations

Hudecki, Andrzej, Nahid Rezvani Jalal, Tayyebeh Madrakian, et al.. (2022). Biodegradable and Non-Biodegradable Biomaterials and Their Effect on Cell Differentiation. International Journal of Molecular Sciences. 23(24). 16185–16185. 34 indexed citations

Aghaei, Mahmoud, Marveh Rahmati, Filip Machaj, et al.. (2021). The Role of BiP and the IRE1α–XBP1 Axis in Rhabdomyosarcoma Pathology. Cancers. 13(19). 4927–4927. 11 indexed citations

Hashemi, Mohammad, Shima Karami, Jarosław Śmieja, et al.. (2019). LMO1 polymorphisms and the risk of neuroblastoma: Assessment of meta‐analysis of case‐control studies. Journal of Cellular and Molecular Medicine. 24(2). 1160–1168. 9 indexed citations

10.

Sharifzad, Farzaneh, Saeid Ghavami, Javad Verdi, et al.. (2019). Glioblastoma cancer stem cell biology: Potential theranostic targets. Drug Resistance Updates. 42. 35–45. 132 indexed citations

11.

Hudecki, Andrzej, Joanna Gola, Saeid Ghavami, et al.. (2017). Structure and properties of slow-resorbing nanofibers obtained by (co-axial) electrospinning as tissue scaffolds in regenerative medicine. PeerJ. 5. e4125–e4125. 13 indexed citations

12.

Jain, Mayur Vilas, Anna Paczulla, Thomas Klonisch, et al.. (2013). Interconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development. Journal of Cellular and Molecular Medicine. 17(1). 12–29. 194 indexed citations

13.

Panigrahi, Soumya, et al.. (2009). Obesity: Pathophysiology and Clinical Management. Current Medicinal Chemistry. 16(4). 506–521. 88 indexed citations

14.

Klonisch, Thomas, Emilia Wiecheć, Sabine Hombach‐Klonisch, et al.. (2008). Cancer stem cell markers in common cancers – therapeutic implications. Trends in Molecular Medicine. 14(10). 450–460. 321 indexed citations

15.

Rashedi, Iran, Soumya Panigrahi, Peyman Ezzati, Saeid Ghavami, & Marek Łoś. (2007). Autoimmunity and Apoptosis - Therapeutic Implications. Current Medicinal Chemistry. 14(29). 3139–3151. 42 indexed citations

16.

Krzemieniecki, Krzysztof, et al.. (2006). Targeting of solid tumors and blood malignancies by antibody-based therapies — EGFR-pathway as an example. Open Life Sciences. 1(2). 167–182. 13 indexed citations

17.

Łoś, Marek, Thera P. Links, Jacques W.M. Lenders, & Emile E. Voest. (2000). De ziekte van Von Hippel-Lindau. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 144(11). 497–501. 1 indexed citations

18.

Fulda, Simone, Claudia Friesen, Marek Łoś, et al.. (1997). CD95 (APO-1/Fas)- and p53-independent apoptosis by betulinic acid involves mitochondrial alterations and activation of caspases.. Blood. 90(10). 2207–2207. 2 indexed citations

19.

Debatin, Klaus‐Michael, Claudia Friesen, Ingrid Herr, & Marek Łoś. (1996). Activation of the CD95 pathway by anticancer drugs.. Blood. 88(10). 2641–2641. 1 indexed citations

20.

Łoś, Marek, Wulf Dröge, Kirstin Stricker, Patrick A. Baeuerle, & Klaus Schulze‐Osthoff. (1995). Hydrogen peroxide as a potent activator of T lymphocyte functions. European Journal of Immunology. 25(1). 159–165. 172 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact